Skip to search formSkip to main contentSkip to account menu

basiliximab

Known as: Ig gamma-1 chain C region, basiliximab [Chemical/Ingredient], chimeric mouse-human antiCD25 
A recombinant, chimeric, human-murine monoclonal antibody directed against the alpha subunit of the interleukin-2 receptor (IL-2R alpha) with… 
National Institutes of Health

Related topics

Related topics

9 relations
Drug AllergyGraft-vs-Host DiseaseInterleukin 2 Receptor Antagonists [MoA]Simulect

Broader (3)

Immunosuppressive AgentsMonoclonal AntibodiesRecombinant Fusion Proteins

Narrower (1)

basiliximab 20 MG Injection [Simulect]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Choice of induction regimens on the risk of cytomegalovirus infection in donor‐positive and recipient‐negative kidney transplant recipients
F.L. Luan, M. Samaniego, M. Kommareddi, J.M. Park, A.O. Ojo. Choice of induction regimens on the risk of cytomegalovirus… 
2008
2008
Rituximab in highly sensitized kidney transplant recipients.
2008
2008
Does immunosuppressive pharmacotherapy affect isoagglutinin titers?
2007
2007
Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post‐transplant diabetes
Abstract:  Background:  Steroid minimization regimens have become increasingly popular for kidney transplant recipients. We… 
2006
2006
Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
2005
2005
Induction therapy with either anti‐CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C
Abstract:  Background:  Hepatitis C virus (HCV)‐related end‐stage liver disease (ESLD) is the leading cause for orthotopic liver… 
Review
2003
Review
2003
Minimizing calcineurin inhibitor drugs in renal transplantation.
Highly Cited
2002
Highly Cited
2002
Immunoprophylaxis with basiliximab, a chimeric anti–interleukin‐2 receptor monoclonal antibody, in combination with azathioprine‐containing triple therapy in liver transplant recipients
Acute graft rejection remains a major problem among additional sequelae in liver transplant recipients. Basiliximab, a chimeric… 
2000
2000
Immunosuppression for pediatric cardiac transplantation in the modern era.
Highly Cited
1999
Highly Cited
1999
Basiliximab. Point of view
The chimaeric monoclonal antibody basiliximab specifically binds the α subunit of the interleukin-2 (IL-2) receptor on activated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)